Asia-Pacific Pruritus Therapeutics Market Gains Momentum as Itch Relief Takes Center Stage | At a CAGR of 4.7%
The Asia-Pacific Pruritus Therapeutics Market is experiencing substantial growth due to the rising prevalence of pruritus, commonly known as itchiness, among the population. Pruritus is a symptom associated with various underlying health conditions such as dermatological disorders, liver diseases, kidney disorders, and autoimmune diseases. It is a distressing condition that significantly affects the quality of life of individuals. Consequently, there is a growing demand for pruritus therapeutics in the Asia-Pacific region. The market is driven by advancements in research and development activities, leading to the introduction of novel and effective treatment options. The Asia-Pacific Pruritus Therapeutics Market was valued at $2.0 billion in 2022 and is projected to reach $3.2 billion by 2032, registering a CAGR of 4.7% from 2023 to 2032. ๐๐๐ญ ๐๐จ๐ซ๐ ๐๐๐๐ฎ๐ซ๐๐ญ๐ ๐๐ง๐๐จ๐ซ๐ฆ๐๐ญ๐ข๐จ๐ง ๐๐๐ซ๐ ๐๐ข๐ญ๐ก ๐๐ญ๐๐ญ๐ฌ: (Sample Copy) https://www.alliedmarketresearch.com/reques...